Vera Bradley, Inc., together with its subsidiaries, designs and manufactures women's handbags, luggage and travel items, fashion and home accessories, and gifts in the United States. It operates in three segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The company offers bag products, such as backpacks, totes, crossbodies, lunch bags, satchels, clutches, and baby bags; accessories, including ID holders, lanyards, wallets, wristlets, eyewear, scarves, various technology accessories, and hair accessories, as well as bracelets, rings, necklaces, tees, and hoodies under the Pura Vida brand. It also provides travel products comprising rolling luggage, cosmetics, travel and packing accessories, and travel bags, which include duffel and weekend bags; home products, such as textiles, throw blankets, beach towels, bedding, mugs, and tumblers; sleepwear, footwear, outerwear, socks, and tops under the Vera Bradley brand; and stationery, licensing, freight, merchandising, and gift card breakage services. The company sells its Vera Bradley branded products through its full-line and outlet stores in the United States; e-commerce sites, such as verabradley.com, outlet.verabradley.com, and international.verabradley.com; and its annual outlet sale in Fort Wayne, Indiana, as well as through specialty retail locations, department stores, national accounts, third party e-commerce sites, third-party inventory liquidators, and through licensing agreements. It sells its Pura Vida branded products through wholesale retailers and department stores; and its Pura Vida website, www.puravidabracelets.com. Vera Bradley, Inc. was founded in 1982 and is headquartered in Roanoke, Indiana.

Vera Bradley Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Fate Therapeutics (FATE) ...

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Fate Therapeutics (FATE) and Mirum Pharmaceuticals (MIRM)

The latest update is out from Virax Biolabs Group Ltd. Class A ( ($VRAX) ). On May 26, 2026, Virax Biolabs reported positive early pilot data for V...

Virax Biolabs Reports Strong Early Data for Long COVID Test and Prepares Larger Validation Study

LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Savara today and set a price target of $9.00. Brisebois covers the Healthcare...

LifeSci Capital Keeps Their Buy Rating on Savara (SVRA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Savara (SVRA), Encompass Health (EHC) and SI-Bone (S...

Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Encompass Health (EHC) and SI-Bone (SIBN)

Zevra Therapeutics, Inc. (($ZVRA)) has held its Q1 earnings call. Read on for the main highlights of the call. Zevra Therapeutics’ latest earnings ...

Zevra Therapeutics Earnings Call Highlights Growth Pivot

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), CG Oncology, Inc. (CGON) ...

Analysts Are Bullish on These Healthcare Stocks: Zevra Therapeutics (ZVRA), CG Oncology, Inc. (CGON)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)...

Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)

Roth MKM analyst maintained a Buy rating on Zevra Therapeutics today and set a price target of $21.00. Zevra Therapeutics has an analyst consensus ...

Zevra Therapeutics (ZVRA) Gets a Buy from Roth MKM

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Savara, with a price target of $16.00. According to TipRan...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	VRA	$3.43	+1.78%	66.49K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	VRA	$3.43	+1.8%	66.49K
3
4
5
6

VRA

VRA

No Data Available

Get Vera Bradley Inc. Data in Excel

Get Vera Bradley Inc. Data in Excel